PTEN acts as a tumour suppressor by dephosphorylating the plasma membrane lipid second messenger phosphoinositide-3,4,5-trisphosphate (PIP3) antagonizing signal transduction downstream of phosphatidylinositol-3 kinase (PI3K) and suppressing cell growth and survival 9. Here, PTEN is linked to neoplasm.